Log In
Print this Print this

PD-1 x LAG-3 DART molecule (MGD013)

  Manage Alerts
Collapse Summary General Information
Company MacroGenics Inc.
DescriptionHumanized bispecific antibody targeting programmed cell death 1 (PD-1; PDCD1; CD279) and lymphocyte-activation gene 3 (LAG3; CD223) developed using Dual-Affinity Re-Targeting (DART) technology
Molecular Target Programmed cell death 1 (PD-1) (PDCD1) (CD279) ; Lymphocyte-activation gene 3 (LAG3) (CD223)
Mechanism of ActionBispecific antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today